We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.Services Agreement Neogenix Oncology, Inc. 31.1C PROJECTServices Agreement • July 16th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 16th, 2010 Company Industry
Services Agreement Neogenix Oncology, Inc.Services Agreement • July 16th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 16th, 2010 Company Industry** Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits information subject to the confidentiality request. Omissions are designated with brackets containing two asterisks “[ ** ]”. As part of our confidential treatment request, a complete version of this exhibit has been filed separately with the Securities and Exchange Commission.
Services Agreement Neogenix Oncology, Inc. H16C3 PROJECTServices Agreement • July 16th, 2010 • Neogenix Oncology Inc • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 16th, 2010 Company Industry** Confidential treatment has been requested for portions of this exhibit. The copy filed herewith omits information subject to the confidentiality request. Omissions are designated with brackets containing two asterisks “[ ** ]”. As part of our confidential treatment request, a complete version of this exhibit has been filed separately with the Securities and Exchange Commission.